Skip to content

Observational Study on the Course of Plasma Glutamine Levels During Critical Illness

Observational Study on the Course of Plasma Glutamine Levels During Critial Illness

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02310035
Enrollment
178
Registered
2014-12-05
Start date
2014-04-30
Completion date
2014-09-30
Last updated
2015-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glutamine Levels

Brief summary

Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission

Detailed description

All patients who are admitted to the ICU after elective surgery and non-elective admissions. In both groups a total of 80 patients will be included. (In the trials we mentioned in the introduction 80, 174 and 66 patients were included. In the study performed by Oudemans-van Straaten a decent distribution between lower and higher levels of glutamine was achieved in 80 non-elective patients.) Exclusion criteria are patients younger then 18 years and patients who need total parenteral nutrition (TPN). The patients will receive standard care during their treatment on the ICU. Blood sampled for standard evaluation will be used for determination of plasma glutamine by Bioprofile Flex Glutamine Sensor at ICU admission. Hereafter plasma glutamine will be measured daily, a plasma sample will be taken from a standard evaluation blood sample at 6.00 am during admission on the ICU.

Interventions

None listed

Sponsors

Frisius Medisch Centrum
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients admitted to the ICU

Exclusion criteria

* younger then 18 years and patients who need total parenteral nutrition

Design outcomes

Primary

MeasureTime frameDescription
glutamine in serumfrom admission up to 8 daysglutamine level at admission and during ICU stay daily

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026